Explore Business Standard
Drug Prices
US President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the US. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now rein in Medicaid drug prices to match what they charged in other developed countries. As part of the deal, new drugs made by those companies will also be charged at the so-called most-favoured-nation pricing across the country on any newly launched medications for all, including commercial and cash pay markets as well as Medicare and Medicaid. Drug prices for patients in the US can depend on a number of factors, including the competition a treatment faces and insurance coverage. Most people have coverage through work, the individual insurance market or government programs like Medicaid and Medicare, which shield them from much of the cost. Patients in Medicaid, the state and federally funded program for peopl
The Delhi Cabinet on Tuesday gave its nod to three major health sector reforms aimed at improving service delivery and infrastructure in government hospitals, including the setting up of a price monitoring and resource unit, and the outsourcing of OPD/IPD registrations and diagnostic services. Delhi Health Minister Pankaj Singh told PTI that the government, in its efforts to enhance health infrastructure, approved three key reforms on Tuedday. He said that the three agenda items -- centred on price regulation, operational outsourcing, and PPP-driven diagnostic services -- reflect the government's focus on strengthening healthcare delivery and governance in the capital. Every day, the Delhi government is taking steps to provide the best facilities in our hospitals, Singh said.